Therapy with ACE inhibitors. what kind of risk make them indispensible?
Kleber, F.X.
MMW Fortschritte der Medizin 142(46): 44-45
2000
ISSN/ISBN: 1438-3276 PMID: 11132312 Document Number: 516865
Document emailed within 1 workday
Related Documents
Baldini, E.; Prochilo, T. 2004: The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: what kind of evidence? I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S79-S80Kremer, B.; Henne-Bruns, D.; Grimm, H. 1997: Instrumental diagnosis for therapy decision making--what is possible and desirable, what is indispensible and what is superfluous in tumors of the pancreas? Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 114: 379-382
Bordin, D.S.; Masharova, A.A.; Lazebnik, L.B. 2008: Long-term therapy of acid-dependent diseases with proton pump inhibitors and risk of colorectal cancer (literature review) Eksperimental'naia i Klinicheskaia Gastroenterologiia 2008(4): 36-38
Hermann, R. 1999: The internet will soon be indispensible for physicians MMW Fortschritte der Medizin 141(48): 8
Vijan, S.G. 2009: Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients Journal of the Indian Medical Association 107(3): 178-182
Bezruchko, M.V.; Malyk, S.V.; Kravchenko, S.P.; Osipov, O.S.; Sytnik, D.A. 2013: Dependence of the operation stress degree from the kind of operative intervention for an acute cholecystitis in the patients with high operative-anesthesiological risk Klinichna Khirurhiia 3: 22-25
Cao, G.W. 2017: Innovations on technology, management and concept are indispensible for scientific research, prevention and treatment of malignant tumor in China Zhonghua Liu Xing Bing Xue Za Zhi 38(1): 3-12
Mahendran, R. 2006: The risk of suicidality with selective serotonin reuptake inhibitors Annals of the Academy of Medicine Singapore 35(2): 96-99
Coleman, C.I.; White, C.M. 2007: A comparison of different protease inhibitors on coronary heart disease risk Connecticut Medicine 71(1): 15-17
Opolski, A.; Wietrzyk, J. 2001: Inhibitors of neoangiogenesis in antineoplastic therapy Postepy Higieny i Medycyny Doswiadczalnej 55(3): 369-385
Dredge, K.; Dalgleish, A.G.; Marriott, J.B. 2003: Angiogenesis inhibitors in cancer therapy Current Opinion in Investigational Drugs 4(6): 667-674
Manrique, R. 1984: Protease inhibitors and antifibrinolytic therapy Arquivos Brasileiros de Cardiologia 43(5): 355-360
Schoenberger, J.A. 1988: ACE inhibitors as initial therapy for hypertension American Family Physician 37(4): 139-146
Torres, G. 1996: Tuberculosis therapy and the new protease inhibitors Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 10(11): 11-12
Hermanides, R.S.; Ottervanger, J.P.; ten Berg, J.M.; Gosselink, A.T.M.; van Houwelingen, G.; Dambrink, J.-H.E.; Stella, P.R.; Hamm, C.; van 't Hof, A.W.J. 2012: Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score Journal of Invasive Cardiology 24(3): 84-89
Sommadossi; Murphy 1997: Protease Inhibitors Therapy for AIDS Patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 1(5): 226-229
Kraevskiĭ, A.A.; Galegov, G.A. 1992: Reverse transcriptase inhibitors and the therapy of HIV infection Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1992(11-12): 3-6
Michel-Briand, Y. 1982: New aspects of antibiotic therapy: enzyme inhibitors Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 176(4): 454-468
Schoenberger, J.A. 1988: ACE inhibitors as initial therapy for hypertension [correction American Family Physician 38(2): 65
Kuhl, H. 1991: Does an increase in endogenous estradiol in treatment with low-dose ovulation inhibitors signify increased risk? Geburtshilfe und Frauenheilkunde 51(6): 492